Evidence map›Paper›PMID 28395565›Full record

ArticleLeukemia & lymphoma2017

Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy.

Neel K Gupta, Chia-Ching Wang, Gabriel N Mannis, John-Paul J Yu, James L Rubenstein

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Biology of CNS lymphoma and the potential of novel agents.Hematology. American Society of Hematology. Education Program · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neel K Guptaa Division of Hematology/Oncology , University of California , San Francisco , CA , USA.
Chia-Ching Wanga Division of Hematology/Oncology , University of California , San Francisco , CA , USA.
Gabriel N Mannisa Division of Hematology/Oncology , University of California , San Francisco , CA , USA.
John-Paul J Yuc Department of Radiology , University of California , San Francisco , CA , USA.
James L Rubensteina Division of Hematology/Oncology , University of California , San Francisco , CA , USA.

Funding

The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's LymphomaR01CA139083 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2009 to 2018
$3.4M
Targeted Therapies in CNS LymphomasR21CA184694 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2014 to 2015
$378k
NCI NIH HHS R01 CA139083NCI NIH HHS R21 CA184694
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acquired Immunodeficiency SyndromeAdultAntineoplastic Combined Chemotherapy ProtocolsAntiretroviral Therapy, Highly ActiveCentral Nervous System NeoplasmsDrug Resistance, ViralFemaleHumansLenalidomideLymphoma, AIDS-RelatedThalidomideTreatment OutcomeLenalidomideThalidomide

Identifiers

PMID28395565
PMCPMC6026016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.